City Center Advisors LLC’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Sell
619
-118
-16% -$47K 0.2% 149
2026
Q2
$267K Sell
737
-63
-8% -$21.6K 0.22% 142
2026
Q1
$282K Sell
800
-256
-24% -$91.3K 0.26% 117
2025
Q4
$346K Buy
1,056
+186
+21% +$59K 0.32% 98
2025
Q3
$246K Sell
870
-345
-28% -$100K 0.24% 131
2025
Q2
$339K Buy
1,215
+498
+69% +$141K 0.36% 91
2025
Q1
$223K Buy
+717
New +$212K 0.26% 136
2024
Q4
– Sell
-684
Closed -$220K – 158
2024
Q3
$220K Buy
+684
New +$224K 0.25% 148

Other funds holding AMGN

City Center Advisors LLC's AMGN Position: Q3 2026 in Review

City Center Advisors LLC reduced its Amgen (AMGN) stake by 16% in Q3 2026, selling an estimated $47K and leaving 619 shares worth $261K. The position accounts for 0.2% of the portfolio, ranked #149.

City Center Advisors LLC first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $346K in Q4 2025. 112 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • City Center Advisors LLC held 619 shares of Amgen worth $261K as of Q3 2026.
  • City Center Advisors LLC sold 118 Amgen shares in Q3 2026, an estimated $47K.
  • Amgen made up 0.2% of City Center Advisors LLC's portfolio in Q3 2026, its #149 holding.
  • City Center Advisors LLC first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • City Center Advisors LLC's Amgen position peaked at $346K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on City Center Advisors LLC's 13F filing for Q3 2026, filed 8 Oct 2026.